Clinical Research Directory
Browse clinical research sites, groups, and studies.
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Sponsor: Francis Medical Inc.
Summary
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Official title: Vanquish® Water Vapor Ablation for PrOstate CanceR: Long-Term Registry
Key Details
Gender
MALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
2500
Start Date
2026-04-30
Completion Date
2041-07-31
Last Updated
2026-03-06
Healthy Volunteers
No
Conditions
Interventions
Vanquish Therapy
The Francis Medical, Inc. Vanquish Water Vapor Ablation Device ("Vanquish" or "Vanquish System") is a transurethral thermal water vapor ablation device. The Vanquish System is designed ablate prostate tissue, while minimizing side effects.